Evidence map›Paper›PMID 40997832›Full record

ArticleEnvironmental microbiology reports2025

Genomic Analysis and Virulence Features of Vibrio cholerae Non-O1/Non-O139 Harbouring CARB-Type β-Lactamases From Freshwater Bodies, Argentina.

Daiana Guevara Núñez, Fabrizzio N Morandini, Geehan Suleyman, Kyle Crooker, Jagjeet Kaur, Gina Maki, José L Bocco, Darío Fernández Do Porto, Markus J Zervos, Claudia Sola and 1 more

Abstract read
In one paragraph

Article in Environmental microbiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Daiana Guevara NúñezInstituto de Química, Física de los Materiales, Medioambiente y Energía (IQUIBICEN), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Fabrizzio N MorandiniCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Provincia de Córdoba, Argentina.
Geehan SuleymanHenry Ford Health System, Detroit, Michigan, USA.
Kyle CrookerHenry Ford Health System, Detroit, Michigan, USA.
Jagjeet KaurHenry Ford Health System, Detroit, Michigan, USA.
Gina MakiHenry Ford Health System, Detroit, Michigan, USA.
José L BoccoCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Provincia de Córdoba, Argentina.
Darío Fernández Do PortoInstituto de Química, Física de los Materiales, Medioambiente y Energía (IQUIBICEN), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Facultad de Ciencias Exactas y Naturales, Universidad Nacional de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Markus J ZervosHenry Ford Health System, Detroit, Michigan, USA.
Claudia SolaCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Provincia de Córdoba, Argentina.
H Alex SakaCentro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Provincia de Córdoba, Argentina.ORCID https://orcid.org/0000-0002-8754-7337

Funding

Agencia Nacional de Promoción Científfica y Tecnológica (ANPCyT)-Ministerio de Ciencia y Tecnología (MINCyT) PICT2018-03004Internal Funding Henry Ford HospitalSecretaría de Ciencia y Tecnología-Universidad Nacional de Córdoba (SECyT-UNC) CONSOLIDAR2018Secretaría de Ciencia y Tecnología-Universidad Nacional de Córdoba (SECyT-UNC) NRO.PIP33620180100715CB
6 · The paper itself

Abstract

Vibrio cholerae is a globally distributed, free-living bacterium in aquatic ecosystems. While non-O1/non-O139 serogroups typically do not produce cholera toxin, they have the potential to cause diarrhoea. These strains may act as reservoirs of antibiotic resistance in rivers, lakes and oceans. Understanding their genetic resistance and virulence can shed light on their role in spreading antimicrobial resistance and their pathogenicity. In this study, we characterised 60 V. cholerae non-O1/non-O139 strains from 16 freshwater bodies located throughout the Province of Córdoba, Argentina. We found none of the strains carried cholera toxin and identified ampicillin resistance as the most prevalent phenotype. Whole genome sequencing revealed that all ampicillin-resistant strains (n = 10) carried CARB β-lactamases, leading to the identification of new CARB variants (CARB-59 to CARB-62) likely associated with the V. cholerae superintegron. Two strains were notably related and exhibited enhanced virulence due to an unusual genetic arrangement of the VPI-1 pathogenicity island, encoding both the toxin co-regulated pilus and a type VI secretion system cluster subclass i5, commonly found in non-cholera Vibrio species. These findings provide significant insights into the genetic diversity and virulent potential of ampicillin-resistant environmental V. cholerae non-O1/non-O139 and enhance our understanding of the evolution of CARB β-lactamases within the species.

Indexed as

beta-LactamasesFresh WaterVibrio choleraeVibrio cholerae non-O1Ampicillin ResistanceAnti-Bacterial AgentsArgentinaBacterial ProteinsGenome, BacterialGenomic IslandsPhylogenyVirulenceVirulence FactorsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesVirulence Factorsantibiotic resistancebacteriabeta‐lactamasesinfectious agents in the environment

Identifiers

PMID40997832
PMCPMC12463395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.